​

LENZ Therapeutics (LENZ) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

LENZ Therapeutics Revenue Highlights

Latest Revenue (Y)

$19.09M

Latest Revenue (Q)

$5.00M

Main Segment (Y)

License

LENZ Therapeutics Revenue by Period

LENZ Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$19.09M100.00%
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$15.00M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

LENZ Therapeutics generated $19.09M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

LENZ Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30$5.00M100.00%
2025-03-31--100.00%
2024-12-31$66.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

LENZ Therapeutics generated $5.00M in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

LENZ Therapeutics Revenue Breakdown

LENZ Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
License$17.50M
Product$1.59M

LENZ Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (91.68%), and Product (8.32%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25
License$12.50M$5.00M-
Reportable Segment--$5.00M

LENZ Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: License (100.00%).

LENZ Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GERNGeron$183.88M$47.23M
SPRYARS Pharmaceuticals$84.28M$32.50M
MRVIMaravai LifeSciences$49.87M$41.63M
NBTXNanobiotix$30.06M$30.06M
LENZLENZ Therapeutics$19.09M$5.00M
ABUSArbutus Biopharma$14.08M$529.00K
PRMEPrime Medicine$4.63M$1.23M
RZLTRezolute--
SVRASavara--
GHRSGH Research-$80.00K
TYRATyra Biosciences--

LENZ Revenue FAQ

What is LENZ Therapeutics’s yearly revenue?

LENZ Therapeutics's yearly revenue for 2025 was $19.09M, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. LENZ's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022.

What is LENZ Therapeutics’s quarterly revenue?

LENZ Therapeutics's quarterly revenue for Q2 2025 was $5M, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). LENZ's quarterly revenue for Q4 2024 was $66K, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is LENZ Therapeutics’s revenue growth rate?

LENZ Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.

What are LENZ Therapeutics’s revenue streams?

LENZ Therapeutics's revenue streams in c 25 are License, and Product. License generated $17.5M in revenue, accounting 91.68% of the company's total revenue Product generated $1.59M in revenue, accounting 8.32% of the company's total revenue

What is LENZ Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of LENZ Therapeutics was License. This segment made a revenue of $17.5M, representing 91.68% of the company's total revenue.